Muller, J., Bolomsky, A., Dubois, S., Duray, E., Stangelberger, K., Plougonven, E., . . . Caers, J. (2018). Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease. Haematologica.
Citación estilo ChicagoMuller, Joséphine, et al. "Maternal Embryonic Leucine Zipper Kinase Inhibitor OTSSP167 Has Preclinical Activity in Multiple Myeloma Bone Disease." Haematologica 2018.
Cita MLAMuller, Joséphine, et al. "Maternal Embryonic Leucine Zipper Kinase Inhibitor OTSSP167 Has Preclinical Activity in Multiple Myeloma Bone Disease." Haematologica 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.